Article Text

Download PDFPDF

PO.7.144 ASSESSLE- a new tool to assess sle disease activity- the patients’ perspective
  1. D Paran1,
  2. M Ben-Am2,
  3. L Mendel2,
  4. P Ari1,
  5. V Furer1,
  6. O Elalouf1,
  7. J Wollman1,
  8. T Eviatar1,
  9. S Pel2,
  10. S Kivity3,
  11. O Elkayam1 and
  12. N Agmon-Levin4
  1. 1Department of Rheumatology, Tel-Aviv Medical Center, Sackler Faculty of Medicine, Tel-Aviv University ~ Tel-Aviv ~ Israel
  2. 2Department of Rheumatology, Tel-Aviv Medical Center ~ Tel-Aviv ~ Israel
  3. 3Rheumatology Unit, Meir Medical Center, Sackler Faculty of Medicine, Tel-Aviv University ~ Tel-Aviv ~ Israel
  4. 4Clinical Immunology, Angioedema and Allergy Unit. Center for Autoimmune Diseases, Sheba Medical Center, Sackler Faculty of Medicine, Tel-Aviv University ~ Tel-Aviv ~ Israel

Abstract

Purpose Systemic lupus erythematosus (SLE) is a heterogeneous, waxing and waning, multisystem autoimmune disease. The complexity and clinical unpredictability of SLE challenge the assessment of disease activity over time, especially in every day clinical practice. Multiple clinical disease monitoring instruments have been developed, however they are limited in ability to detect change in disease activity over time, too cumbersome to be utilized in daily practice and do not include patient reported outcomes (PROs).

We aimed to construct a new disease activity score which will simplify and improve disease activity assessment in daily practice, and include PROs. Here we present the PRO component.

Methods The new instrument for the assessment of SLE activity is comprised of 7 visual analogue scales (VAS), which separately address the physician’s global assessment and 6 organ systems. The PRO consists of 5 VAS questions which address general well-being, global disease activity, activities of daily living, medication compliance and mood. The ASSESSLE PRO is compared to the Short Form Health Survey (SF-36) which is a 36-item, patient reported survey of patient health. We applied the ASSESSLE PRO to 46 consecutive patients with SLE attending the rheumatology clinic in 2 tertiary medical centers in Israel.

Results Psychometric evaluation of the reliability of all 5 PRO questions indicated that question 4, regarding compliance, poorly correlated with the other items and lowered the reliability (Cronbach’s α =0.80 95% CI [0.74,0.85]). Following omission of question 4, Cronbach’s α was recalculated, leading to increased internal reliability (Cronbach’s α = 0.86, 95% CI [0.82, 0.90]). All other remaining items had satisfactory correlation with the other items (‘item-other’ correlation between 0.58–0.70). Therefore, the score was computed as the mean of the 4 remaining questions. Aiming to compare the ASSESSLE PRO to the SF-36 survey, Spearman correlation coefficient between absolute scores was computed and a strong and significant effect was found (R=0.85, p<0.0001) (figure 1).

Conclusions The ASSESSLE PRO is a short PRO which allows a reliable, reproducible and simple PRO form showing excellent correlation with the SF-36. Following omission of question 4, regarding patient compliance, the ASSESSLE PRO consists of only 4 questions, as compared to the SF-36 which requires a response to 36 items. The ASSESSLE PRO seems to have significant advantages due to its intuitive VAS questions and brevity which allows use of this PRO in every day practice and may increase validity of disease activity evaluation of SLE when combined with the physician’s assessment.

http://creativecommons.org/licenses/by-nc/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.